Brief: Panbela Reports Q2 2022 Financial Results
15/08/2022 21:11
Aug 15 (Reuters) - Panbela Therapeutics Inc PBLA.O :
* PANBELA PROVIDES BUSINESS UPDATE AND REPORTS Q2 2022
FINANCIAL
RESULTS
* Q2 LOSS PER SHARE $1.51
Source text for Eikon: ID:nGNXc2wqdK
Further company coverage: PBLA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Panbela Therapeutics
See all newsBrief: Panbela Therapeutics Announces Third Independent Safety Review Of Phase 3 Aspire Clinical Trial DSMB Recommended Continuation With No Trial Modification
Brief: Nasdaq Notifies Panbela Therapeutics Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard
Brief: Panbela Announces Pricing of Approximately $9 Mln Public Offering
U.S. STOCKS ON THE MOVE-Fisker, Best Buy, NuStar Energy
Brief: Panbela Therapeutics Announces Exercise Of Warrants And Issuance Of New Warrants